Long-term Continuous 5-Fluorouracil Infusion in Patients with Advanced Head and Neck Cancer

By Sørensen Peter   Andersen Lisbeth J.   Hansen Olfred   Bastholt Lars  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1043-1045

Informa Healthcare

Access to resources Recommend Favorite

Concurrent Radiotherapy and Continuous Ambulatory Infusion 5-Fluorouracil in Advanced Head and Neck Cancer

By Olver I.N.   Hughes P.G.   Smith J.G.   Narayan K.   Bishop J.F.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 249-254

Elsevier

Access to resources Recommend Favorite

A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

By Oh Sung Yong   Kwon Hyuk-Chan   Seo Bong-Gun   Kim Sung-Hyun   Kim Jae-Seok   Kim Hyo-Jin  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 336-341

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: A hellenic cooperative oncology group phase II study

By Fountzilas George   Tolis Christos   Kalogera-Fountzila Anna   Misailidou Despina   Tsekeris Periklis   Karina Maria   Nikolaou Angelos   Samantas Epaminondas   Makatsoris Thomas   Athanassiou Eleni   Skarlos Dimosthenis   Bamias Aristotelis   Zamboglou Nikolas   Economopoulos Theofanis   Karanastassi Sophia   Pavlidis Nicholas   Daniilidis John  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 269-279

Humana Press, Inc

Access to resources Recommend Favorite

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

By Zhu Xiaodong   Leaw Jiin   Gu Weilie   Qian Yiying   Du Hongyu   Wang Biyun   Hong Xiaonan   Yin Jiliang  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 929-936

Springer Publishing Company

Access to resources Recommend Favorite